Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Goodwill (2016 - 2021)

Kiora Pharmaceuticals (KPRX) has disclosed Goodwill for 6 consecutive years, with $3.5 million as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Goodwill rose 128.36% year-over-year to $3.5 million, compared with a TTM value of $3.5 million through Sep 2021, up 128.36%, and an annual FY2020 reading of $3.6 million, up 137.96% over the prior year.
  • Goodwill was $3.5 million for Q3 2021 at Kiora Pharmaceuticals, up from $146605.0 in the prior quarter.
  • Across five years, Goodwill topped out at $5.4 million in Q1 2017 and bottomed at $146605.0 in Q2 2021.
  • Average Goodwill over 5 years is $2.9 million, with a median of $1.5 million recorded in 2017.
  • The sharpest move saw Goodwill skyrocketed 256.37% in 2017, then tumbled 90.39% in 2021.
  • Year by year, Goodwill stood at $1.5 million in 2017, then changed by 0.0% to $1.5 million in 2018, then changed by 0.0% to $1.5 million in 2019, then skyrocketed by 137.96% to $3.6 million in 2020, then dropped by 4.03% to $3.5 million in 2021.
  • Business Quant data shows Goodwill for KPRX at $3.5 million in Q3 2021, $146605.0 in Q2 2021, and $3.6 million in Q1 2021.